Mucosal Immunization with Iron Receptor Antigens Protects against Urinary Tract Infection
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Uncomplicated infections of the urinary tract, caused by uropathogenic Escherichia coli, are among the most common diseases requiring medical intervention. A preventive vaccine to reduce the morbidity and fiscal burden these infections have upon the healthcare system would be beneficial. Here, we describe the results of a large-scale selection process that incorporates bioinformatic, genomic, transcriptomic, and proteomic screens to identify six vaccine candidates from the 5379 predicted proteins encoded by uropathogenic E. coli strain CFT073. The vaccine candidates, ChuA, Hma, Iha, IreA, IroN, and IutA, all belong to a functional class of molecules that is involved in iron acquisition, a process critical for pathogenesis in all microbes. Intranasal immunization of CBA/J mice with these outer membrane iron receptors elicited a systemic and mucosal immune response that included the production of antigen-specific IgM, IgG, and IgA antibodies. The cellular response to vaccination was characterized by the induction and secretion of IFN-gamma and IL-17. Of the six potential vaccine candidates, IreA, Hma, and IutA provided significant protection from experimental infection. In immunized animals, class-switching from IgM to IgG and production of antigen-specific IgA in the urine represent immunological correlates of protection from E. coli bladder colonization. These findings are an important first step toward the development of a subunit vaccine to prevent urinary tract infections and demonstrate how targeting an entire class of molecules that are collectively required for pathogenesis may represent a fundamental strategy to combat infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





![Figure 6 Isotype class-switching and urinary IgA correlates with vaccine-mediated protection from infection. (A) The Class Switch Index was calculated by dividing the change in serum IgG absorbance for the entire group of vaccinated mice (accounting for non-specific increases by subtracting the corresponding median change in IgG absorbance for the CT-vaccinated mouse cohort) by the same computation preformed with group median IgM absorbance values [(ΔIgGVAC−ΔIgGCT)/(ΔIgMVAC−ΔIgMCT)]. The Class Switch Index was then plotted against the normalized bladder CFU (group median CFUVAC/group median CFUCT) for each vaccination experiment. Thus, each individual point reflects the collective data from an experiment involving 10 vaccinated and 10 CT mice (n = 203). Lower normalized CFU values indicate enhanced bacterial clearance after challenge, where higher class switch indices represent superior B cell activation by comparing the increase in IgG compared to the increase in IgM. (B) Normalized bladder CFU values from each vaccination experiment are plotted against the median change in absorbance of antigen-specfic IgA detected in the urine (ΔIgAVAC). Pearson correlation coefficient (r) and P values are shown.](https://figures.cochat.ai/paper-figures/4ade885dc2df4b6abbe6fe8de5cd08ec/mucosal-immunization-with-iron-receptor-antigens-protects-against-urinary-tract-figure-6.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, Alteri et al. used a large-scale vaccinology approach to identify candidate uropathogenic E. coli vaccine antigens and found that immunization with six outer membrane iron receptors protected against UTI (Alteri et al., 2009).”
From Iron in infection and immunity (2013) · cites this paper as Alteri et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
INDUCTION OF TH1 AND TH2 CD4+T CELL RESPONSES:The Alternative Approaches
Constant, S. L., & Bottomly, K. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.297 · Cited by 1,459
Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing
Pizza, M., Scarlato, V., Masignani, V., Giuliani, M. M., Aricò, B., Comanducci, M., Jennings, G. T., Baldi, L., Bartolini, E., Capecchi, B., et al. (2000) · Science · doi:10.1126/science.287.5459.1816 · Cited by 1,399
Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract.
Connell, I., Agace, W., Klemm, P., Schembri, M., Mărild, S., & Svanborg, C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9827 · Cited by 735
Gupta, K., Hooton, T. M., & Stamm, W. E. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-1-200107030-00012 · Cited by 677
Crystal structure of the outer membrane active transporter FepA from Escherichia coli.
Buchanan (1999) · Nature Structural Biology · doi:10.1038/4931 · Cited by 591
Prevention of Mucosal Escherichia coli Infection by FimH-Adhesin-Based Systemic Vaccination
Langermann, S., Palaszynski, S., Barnhart, M., Auguste, G., Pinkner, J. S., Burlein, J., Barren, P., Koenig, S., Leath, S., Jones, C. H., et al. (1997) · Science · doi:10.1126/science.276.5312.607 · Cited by 577
Mobley, H. L., Green, D. M., Trifillis, A. L., Johnson, D. E., Chippendale, G. R., Lockatell, C. V., Jones, B. D., & Warren, J. W. (1990) · Infection and Immunity · doi:10.1128/iai.58.5.1281-1289.1990 · Cited by 561
Self-citationUmemura, M., Yahagi, A., Hamada, S., Begum, M. D., Watanabe, H., Kawakami, K., Suda, T., Sudo, K., Nakae, S., Iwakura, Y., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3786 · Cited by 519
Shibata, K., Yamada, H., Hara, H., Kishihara, K., & Yoshikai, Y. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4466 · Cited by 483
Interleukin-17 and Lung Host Defense against Klebsiella pneumoniae Infection
Ye, P., Garvey, P. B., Zhang, P., Nelson, S., Bagby, G., Summer, W. R., Schwarzenberger, P., Shellito, J. E., & Kolls, J. K. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.3.4424 · Cited by 461
Cited by
Items 101–200 of 201
Karam, M. R. A., Habibi, M., & Bouzari, S. (2016) · Biologicals · doi:10.1016/j.biologicals.2016.06.006 · Cited by 22
Li, G., Cai, W., Hussein, A., Wannemuehler, Y. M., Logue, C. M., & Nolan, L. K. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.05.044 · Cited by 21
Vaccination Approaches for the Prevention of Urinary Tract Infection
Moriel, D. G., & Schembri, M. A. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201014666131226144824 · Cited by 21
Evaluation and management of recurrent urinary tract infections in children: state of the art
Awais, M., Rehman, A., Baloch, N. U.-A., Khan, F., & Khan, N. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.991717 · Cited by 21
UTI patients have pre-existing antigen-specific antibody titers against UTI vaccine antigens
Sarkissian, C. A., Alteri, C. J., & Mobley, H. L. T. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.07.031 · Cited by 19
Self-citationMular, A., Piasta, K., Jedyńczuk, A., Kamińska, K., Olshvang, E., Metzler‐Nolte, N., Wojaczyńska, E., Kozłowski, H., & Gumienna‐Kontecka, E. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215551 · Cited by 22
Infecciones del tracto urinario, inmunidad y vacunación
Luna-Pineda, V. M., Ochoa, S. A., Cruz‐Córdova, A., Cázares‐Domínguez, V., Vélez-González, F., Hernández‐Castro, R., & Xicohtencatl‐Cortés, J. (2018) · Boletín Médico del Hospital Infantil de México · doi:10.24875/bmhim.m18000011 · Cited by 18
Habibi, M., Karam, M. R. A., & Bouzari, S. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.05.027 · Cited by 18
What is the role of covert infection in detrusor overactivity, and other LUTD? ICI-RS 2013
Moore, K. H., & Malykhina, A. P. (2014) · Neurourology and Urodynamics · doi:10.1002/nau.22589 · Cited by 17
Virulence and Fitness Determinants of Uropathogenic Escherichia coli
Subashchandrabose, S., & Mobley, H. L. T. (2016) · ASM Press eBooks · doi:10.1128/9781555817404.ch12 · Cited by 26
Self-citationBroad protective vaccination against systemic Escherichia coli with autotransporter antigens
Xing, Y., Clark, J. R., Chang, J. D., Chirman, D. M., Green, S. I., Zulk, J. J., Jelinski, J., Patras, K. A., & Maresso, A. W. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011082 · Cited by 18
Uncovering phenotypic inheritance from single cells with Microcolony-seq
Faigenbaum-Romm, R., Yedidi, N., Gefen, O., Katsowich, N., Aroeti, L., Ronin, I., Bar‐Meir, M., Rosenshine, I., & Balaban, N. Q. (2025) · Cell · doi:10.1016/j.cell.2025.08.001 · Cited by 17
Bacterial proteomics and identification of potential vaccine targets
Walters, M. S., & Mobley, H. L. T. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.12 · Cited by 16
Self-citationRezaei, M., Esmaeili, F., Karam, M. R. A., Ehsani, P., Farsangi, Z. A., & Bouzari, S. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109999 · Cited by 17
de Jonge, E. F., Vogrinec, L., van Boxtel, R., & Tommassen, J. (2022) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2022.100172 · Cited by 14
Huo, C., Zeng, X., Xu, F., Li, F., Li, D., Li, G., Hu, Z., Hu, Y., Lin, J., & Sun, H. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.610196 · Cited by 14
Bioinformatics analysis of bacterial protective antigens in manually curated Protegen database
He, Y. O., & Xiang, Z. (2012) · Procedia in Vaccinology · doi:10.1016/j.provac.2012.04.002 · Cited by 13
Sabharwal, N., Chhibber, S., & Harjai, K. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.10.018 · Cited by 13
Jabif, M. F., Gumina, E., Hall, J. W., Hernández-Velasco, X., & Layton, S. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.640228 · Cited by 13
Bettin, E. B., Dorneles, J., Hecktheuer, A. S., Madruga, A. B., Neto, A. C. P. S., McBride, A. J. A., Oliveira, T. L., Grassmann, A. A., & Dellagostin, O. A. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11726-9 · Cited by 16
Berke, K., Sun, P., Ong, E., Sanati, N., Huffman, A., Brunson, T., Loney, F., Ostrow, J., Racz, R., Zhao, B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.639491 · Cited by 14
Fortney, K. R., Smith, S. N., van Rensburg, J. J., Brothwell, J. A., Gardner, J. J., Katz, B. P., Ahsan, N., Duerfeldt, A. S., Mobley, H. L. T., & Spinola, S. M. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02430-21 · Cited by 13
Self-citationSabharwal, N., Chhibber, S., & Harjai, K. (2015) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2015.11.002 · Cited by 11
Habibi, M., Karam, M. R. A., & Bouzari, S. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.02.023 · Cited by 11
Proteomic analysis of uropathogenicEscherichia coli
Cash, P. (2014) · Expert Review of Proteomics · doi:10.1586/14789450.2014.877845 · Cited by 15
Mike, L. A., Tripathi, A., Blankenship, C. M., Saluk, A., Schultz, P. J., Tamayo‐Castillo, G., Sherman, D. H., & Mobley, H. L. T. (2017) · Chemical Communications · doi:10.1039/c7cc07732g · Cited by 11
Self-citationIron Therapeutics in Women’s Health: Past, Present, and Future
Mintz, J. A., Mirza, J., Young, E., & Bauckman, K. (2020) · Pharmaceuticals · doi:10.3390/ph13120449 · Cited by 12
Gao, Q., Xia, L., Liu, J., Wang, X., Gao, S., & Liu, X. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.08.032 · Cited by 11
Natural Approaches for Controlling Urinary Tract Infections
Amalaradjou, M. A. R., & Venkitanaray, K. (2011) · InTech eBooks · doi:10.5772/25079 · Cited by 10
Conover, M. S., Hibbing, M. E., & Hultgren, S. J. (2014) · Springer eBooks · doi:10.1007/978-3-7091-0715-7_52 · Cited by 10
The Potential Role of Persister Cells in Urinary Tract Infections
Durrani, B., Mohammad, A., Ljubetic, B. M., & Dobberfuhl, A. D. (2023) · Current Urology Reports · doi:10.1007/s11934-023-01182-5 · Cited by 11
Pilewski, K. A., Kramer, K. J., & Georgiev, I. S. (2021) · Vaccines · doi:10.3390/vaccines9090964 · Cited by 8
Serum Iron Parameters and Acute Experimental EHV-1 Infection in Horses
Brosnahan, M. M., Erb, H. N., Perkins, G. A., Divers, T. J., Borges, A. S., & Osterrieder, N. (2012) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2012.00963.x · Cited by 10
Why Serological Responses during Cystitis are Limited
Choi, H. W., & Abraham, S. N. (2016) · Pathogens · doi:10.3390/pathogens5010019 · Cited by 7
Wang, Y., Perepelov, A. V., Senchenkova, S. N., Lu, G., Wang, X., Ma, G., Yang, Q., Yuan, J., Wang, Y., Xie, L., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126993 · Cited by 9
Engel, D. R., Wagenlehner, F., & Shevchuk, O. (2024) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2024.03.002 · Cited by 12
Idrees, M. M., & Saeed, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-76320-6_20 · Cited by 9
E. coli Alpha Hemolysin and Properties
Laura, B., Sabina, M., Romina, V., & Vanes, H. (2012) · InTech eBooks · doi:10.5772/33383 · Cited by 11
Pathogenese der Harnwegsinfektion: Ein Update
Magistro, G., Marcon, J., Schubert, S., Gratzke, C., & Stief, C. G. (2017) · Der Urologe · doi:10.1007/s00120-017-0391-7 · Cited by 12
Metabolism and Fitness of Urinary Tract Pathogens
Alteri, C. J., & Mobley, H. L. T. (2015) · ASM Press eBooks · doi:10.1128/9781555818883.ch10 · Cited by 8
Self-citationA Differential Immune Modulating Role of Vitamin D in Urinary Tract Infection.
Pirdel, L., & Pirdel, M. (2020) · Immunological Investigations · doi:10.1080/08820139.2020.1845723 · Cited by 7
Xing, Y., Clark, J. R., Chang, J. D., Zulk, J. J., Chirman, D. M., Piedra, F.-A., Vaughan, E. E., Santos, H. H., Patras, K. A., & Maresso, A. W. (2024) · Infection and Immunity · doi:10.1128/iai.00440-23 · Cited by 6
Proteomics of bacterial pathogenicity: Therapeutic implications
Windle, H. J., Brown, P. A., & Kelleher, D. P. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900145 · Cited by 7
Towards a Vaccine Against Escherichia Coli -Associated Urinary Tract Infections
Serino, L., Moriel, D. G., Rappuoli, R., & Pizza, M. (2010) · Future Microbiology · doi:10.2217/fmb.10.6 · Cited by 6
Current Scientific Advances in Vaccines Against UTIs: Challenges and Prospects
Wang, B., Wang, Y., Liu, H., Yu, M., Wang, S., Liu, L., Wang, H., Zhang, D., & Tan, H. (2025) · Microorganisms · doi:10.3390/microorganisms13122714 · Cited by 10
Urinary tract infections, immunity, and vaccination
Luna-Pineda, V. M., Ochoa, S. A., Cruz‐Córdova, A., Cázares‐Domínguez, V., Vélez-González, F., Hernández‐Castro, R., & Xicohtencatl‐Cortés, J. (2018) · Boletín Médico Del Hospital Infantil de México (English Edition) · doi:10.24875/bmhime.m18000025 · Cited by 5
Karam, M. R. A., Shirzad, A. M., Habibi, M., & Bouzari, S. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.009 · Cited by 5
Host Pathogen Interactions during Catheter-Associated Urinary Tract Infections
Kohler, K. N., Bella, A. A. L., & Flores‐Mireles, A. L. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c01146 · Cited by 6
Reiss, D. J., Engstrom, M. D., & Mobley, H. L. T. (2013) · Springer eBooks · doi:10.1007/978-3-642-30144-5_101 · Cited by 4
Self-citationThe kinase Bud32 regulates iron homeostasis in fungal pathogen Cryptococcus neoformans
Ma, Y., Pan, B., Lei, W., Fang, W., Pan, W., Liao, W., Xu, B., & Xue, P. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1624237 · Cited by 3
Habibi, M., Azimi, S., Khoobbakht, D., Roghanian, P., & Karam, M. R. A. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107638 · Cited by 3
Urinary Tract Infections - New Insights
Hegazy, W. A. H. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.101017 · Cited by 4
Recent Developments in the Treatment of Bacterial Urinary Tract Infections
Kelmis, C., Stephan, K., Varadhan, A. K., Brown, J. B., & Preuss, C. V. (2023) · Springer eBooks · doi:10.1007/978-3-031-20521-7_17 · Cited by 3
Animashaun, T., Adeoye-Isijola, M. O., Naidoo, K., Coopoosamy, R. M., & Olajuyigbe, O. O. (2023) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2687 · Cited by 3
Oxybutynin ameliorates LPS‐induced inflammatory response in human bladder epithelial cells
Chen, C., Li, J., Wang, J., Zhang, M., Zhang, L., & Lin, Z. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23584 · Cited by 3
O uso de vacinas na profilaxia das infecções do trato urinário
Carraro-Eduardo, J. C., & Gava, I. A. (2012) · Brazilian Journal of Nephrology · doi:10.1590/s0101-28002012000200011 · Cited by 3
Bakhtiari, R., Ahmadian, S., & Mehrabadi, J. F. (2016) · Europe PMC (PubMed Central) · Cited by 3
Atto, B., Gell, D. A., Marsh, R. L., & Tristram, S. G. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1548048 · Cited by 2
The Role of Escherichia coli Autotransporters in Urinary Tract Infections and Urosepsis
Krawczyk, B., & Wityk, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199760 · Cited by 4
Pirdel, L., & Pirdel, M. (2021) · Research in Molecular Medicine · doi:10.32598/rmm.9.1.6 · Cited by 3
Kelesidis, T. (2011) · InTech eBooks · doi:10.5772/21939 · Cited by 2
Salah, S. B. M. (2014) · IOSR Journal of Pharmacy and Biological Sciences · doi:10.9790/3008-09530615 · Cited by 2
Chmielewska, S. J., & Leszczyńska, K. (2020) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.21307/pm-2020.59.1.003 · Cited by 3
Microbiota and the Urogenital Tract, Pathogenesis, and Therapies
Tungland, B. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814649-1.00014-4 · Cited by 5
Yang, E., Chee, J. L. Y., Duraiswamy, S., Chen, S., Lees, K., & Chen, S. L. (2019) · Journal of Visualized Experiments · doi:10.3791/58829 · Cited by 2
Hedayat, S., Habibi, M., Doust, R. H., & Karam, M. R. A. (2023) · Bulletin de la Banque nationale de Perse. · doi:10.61186/vacres.10.1.18 · Cited by 1
Dehvari, A., Bameri, Z., Karam, M. R. A., Kord, E., Oloomi, M., Zahedani, S. S., Habibi, M., & Hashemzahi, Z. (2026) · International Journal of Microbiology · doi:10.1155/ijm/9663212 · Cited by 1
Fitness Islands in Uropathogenic Escherichia coli
Lloyd, A. L., & Mobley, H. L. T. (2014) · ASM Press eBooks · doi:10.1128/9781555817114.ch10 · Cited by 1
Self-citationRekurentne infekcije mokraćnih puteva: antimikrobna i imunoaktivna profilaksa
Djukanović, L. (2015) · Биомедицинска истраживања · doi:10.7251/bii1502146dj · Cited by 1
New Strategies for the Prevention of Urinary Tract Infections by Uropathogenic Escherichia coli
Xicohtencatl‐Cortés, J., Ochoa, S. A., Cruz‐Córdova, A., Flores-Oropeza, M. A., & Hernández‐Castro, R. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.108911 · Cited by 1
Recent Insights into the Synthesis of Oligosaccharides from Escherichia coli: Review
Sharma, A., Rabha, P., & Panchadhayee, R. (2024) · Current Organic Chemistry · doi:10.2174/0113852728322510240711045944 · Cited by 1
Vigil, P. D. (2013) · Deep Blue (University of Michigan) · Cited by 1
Urinary Tract Infection: Beyond Uncomplicated Cystitis
Payne, C. K., & Potts, J. M. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-092-2_10 · Cited by 2
Gaddy, J. A. (2010) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Saxena, S. (2020) · International Journal of Medical and Biomedical Studies · doi:10.32553/ijmbs.v4i4.1079 · Cited by 1
Yang, E., Chee, J. L. Y., Duraiswamy, S., Chen, S., Lees, K., & Chen, S. L. (2019) · Journal of Visualized Experiments · doi:10.3791/58829-v · Cited by 1
Flannery, E. L. (2011) · Deep Blue (University of Michigan) · Cited by 2
Nielubowicz, G. R. (2010) · Deep Blue (University of Michigan) · Cited by 1
Santos-Antunes, M. T. (2014) · Gredos (University of Salamanca) · doi:10.14201/gredos.125957 · Cited by 1
Davidrajuh, R. (2009) · InTech eBooks · doi:10.5772/7380
Bueno, P. J. S. (2014) · Gredos (University of Salamanca) · doi:10.14201/gredos.125956
Avaliação e caracterização de candidatos vacinais voltados para o controle da leptospirose.
Teixeira, A. F. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.87.2016.tde-25082016-100745
Siqueira, G. H. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.87.2014.tde-08122014-124353 · Cited by 1
Ripoll, C. A. Q. (2016) · Gredos (University of Salamanca) · doi:10.14201/gredos.132809 · Cited by 1
Sefid, F., Oryani, M. A., Mehdi, M., Payandeh, Z., Khalili, S., Kaffash, E., Azamirad, G., & Kalantar, S. M. (2021) · Research in Molecular Medicine · doi:10.32598/rmm.9.2.3
Sen-Kilic, E. (2020) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.7877
Determination of iron acquisition genes in E. coli from diarrheic calves in arid regions of India
Kumar, S., Suvidhi, Dhial, K., Dhruw, R., Khandelwal, S., & Bhati, T. (2022) · Indian Journal of Animal Health · doi:10.36062/ijah.2022.12522
Xing, Y., Clark, J. R., Chang, J. D., Zulk, J. J., Chirman, D. M., Piedra, F.-A., Patras, K. A., & Maresso, A. W. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.31.543151
Hawas, S. (2024) · Queensland University of Technology · doi:10.5204/thesis.eprints.251490
Iron Receptor Antigen-Based Mucosal Immunization Prevents Urinary Tract Infection
Almanseekanaa, L. H. (2023) · Academic International Journal of Medical Update · doi:10.59675/u125
Periasamy, S., Lübbers, J., King, S. B. S., Hovingh, E. S., van der Fits, L., & van den Dobbelsteen, G. P. J. M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1753331 · Cited by 2
Current progress in developing mRNA-lipid nanoparticle vaccines against human bacterial pathogens
Pullinger, B., Harbison-Price, N., Sebina, I., Na, J., Belz, G. T., & Walker, M. J. (2026) · Clinical Microbiology Reviews · doi:10.1128/cmr.00138-26 · Cited by 2
Iron Uptake in PasteurellaceaePreprint
Phillips, Z. N. (2026) · Research Square · doi:10.21203/rs.3.rs-10023473/v1
Iron Uptake in PasteurellaceaePreprint
Phillips, Z. N. (2026) · Research Square · doi:10.21203/rs.3.rs-10023473/v2
Chimeric vaccine based on Iraqi HLA alleles against a predominant local Escherichia coli phylogroup
Koro, A. T., & Altaii, H. A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1875830
Roier, S., Devant, J. M., Hibbing, M. E., Möbes, A., Kruth, C., Kovacikova, K., Martin, S. M., Phommaly, C., Hannan, T. J., & Jasny, E. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1920497
Akrami, M., Akrami, M., Amini, A., & Haeri, P. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-05214-9
Iron Uptake in PasteurellaceaePreprint
Phillips, Z. N. (2026) · Research Square · doi:10.21203/rs.3.rs-10023473/v3
Metadata
- Authors
- Alteri, C. J., Hagan, E. C., Sivick, K. E., Smith, S. N., & Mobley, H. L. T.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Mobley, Harry L. T.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-09-18
- Volume
- 5
- Issue
- 9
- Pages
- e1000586
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2736566
- OpenAlex
- W2136361919
- Cited by
- 201
- References
- 55
- Citations by year
- 2026: 10 · 2025: 5 · 2024: 5 · 2023: 18 · 2022: 5 · 2021: 12 · 2020: 11 · 2019: 8 · 2018: 11 · 2017: 7 · 2016: 18 · 2015: 20 · 2014: 17 · 2013: 11 · 2012: 12
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (T32GM145304)
- National Institute of Allergy and Infectious Diseases (R01AI043363, R56AI043363, AI043363)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Health Sciences › Medicine › Urology › Urinary Tract Infections Management
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- urinary tract infection, uropathogenic Escherichia coli, mucosal immunization, intranasal vaccine, iron acquisition, outer membrane receptor, vaccine candidate selection, HMA, iutA, iron, iha, chuA, IgA, IgG, interferon-gamma, IL-17, bladder colonization, subunit vaccine, CFT073
- MeSH terms
- Administration, Intranasal, Animals, Antibodies, Bacterial, Antigens, Bacterial, Cells, Cultured, Escherichia coli, Escherichia coli Infections, Female, Immunoglobulin A, Secretory, Interferon-gamma, Mice, Inbred CBA, Recombinant Fusion Proteins, Spleen, Urinary Tract Infections, Immunoglobulin Class Switching, Statistics, Nonparametric, Interleukin-17, Escherichia coli Vaccines, Escherichia coli Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.